The government is asking pharma companies to introduce additional measures, over and above the stockpiles already in place, in the event of a ‘no-deal’ Brexit.
The deadline for Brexit is edging closer, and politicians in the UK are struggling to come to terms with the deal that prime minister Theresa May has negotiated with her European counterparts.<
SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019.
The UK’s pharma industry has welcomed Theresa May's hard won agreement with EU leaders on Brexit, which is already threatened by intense political infighting.
Just two months into his new position as US president and head of commercial for Astellas, Michael Petroutsas joined pharmaphorum editor-in-chief Jonah Comstock for a conversation on the si